Directory
>
Kathryn Packman
Kathryn Packman
Compound Development Leader | The Janssen Pharmaceutical Companies of Johnson & Johnson
Newton, Massachusetts, United States
Kathryn Packman
Summary
Kathryn Packman is a seasoned Clinical and Preclinical Oncology Research and Development Leader with over 20 years of experience in drug discovery and pharmacology. She has a proven track record of leading teams that have successfully delivered more than 30 drugs to clinical stages. With extensive expertise in both small and large molecule drug development, she is known for integrating cutting-edge technologies to enhance preclinical data packages. Kathryn's leadership experience spans various roles at Johnson & Johnson, where she has shaped research project portfolio strategies. Additionally, she serves on the Industry Advisory Board of the Harper Cancer Research Institute, showcasing her commitment to collaborative research. Her academic background includes a Ph.D. in Cell and Molecular Biology from the University of Notre Dame, underscoring her solid foundation in scientific research. Kathryn’s interests lie at the intersection of oncology innovation and translational medicine, making her a valuable asset in the pharmaceutical industry.
Kathryn Packman
Work Experience
Compound Development Leader at
The Janssen Pharmaceutical Companies of Johnson & Johnson
January 2021 - Present
Industry Advisory Board Member at
Harper Cancer Research Institute
January 2017 - Present
Global Head of Tumor Biology at
The Janssen Pharmaceutical Companies of Johnson & Johnson
September 2015 - June 2023
Scientific Director Oncology Collaborations at
The Janssen Pharmaceutical Companies of Johnson & Johnson
October 2013 - August 2015
Head of Preclinical Oncology Research at
ROCHE LEON HOLDINGS
October 2012 - September 2013
Adjunct Professor at
Rutgers Cancer Institute of New Jersey
January 2003 - January 2013
Head of Tumor Biology/ In Vivo Pharmacology at
ROCHE PRODUCTS PTY LTD
April 2002 - October 2012
Postdoctoral Fellow at
UNIVERSITY OF NOTRE DAME
January 2000 - January 2002
Kathryn Packman
Education
SUNY Geneseo, Bs
Frequently Asked Questions about Kathryn Packman
What is Kathryn Packman email address?
Kathryn Packman's primary email address is ********@its.jnj.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Kathryn Packman work for?
Kathryn Packman is a Compound Development Leader at The Janssen Pharmaceutical Companies of Johnson & Johnson, a company specializing in Pharmaceutical & Medicine Manufacturing.
Where Kathryn Packman graduated from?
Kathryn Packman holds a degree in Cell And Molecular Biology from University of Notre Dame.
How can I directly contact Kathryn Packman?
To contact Kathryn Packman directly, you can use the email address ********@its.jnj.com. Complete contact information is available upon registration with Muraena.
Who is Kathryn Packman?
Kathryn Packman is a seasoned Clinical and Preclinical Oncology Research and Development Leader with over 20 years of experience in drug discovery and pharmacology. She has a proven track record of leading teams that have successfully delivered more than 30 drugs to clinical stages. With extensive expertise in both small and large molecule drug development, she is known for integrating cutting-edge technologies to enhance preclinical data packages. Kathryn's leadership experience spans various roles at Johnson & Johnson, where she has shaped research project portfolio strategies. Additionally, she serves on the Industry Advisory Board of the Harper Cancer Research Institute, showcasing her commitment to collaborative research. Her academic background includes a Ph.D. in Cell and Molecular Biology from the University of Notre Dame, underscoring her solid foundation in scientific research. Kathryn’s interests lie at the intersection of oncology innovation and translational medicine, making her a valuable asset in the pharmaceutical industry.
Kathryn`s contact details
********@its.jnj.com
********@janssen.com
Colleagues
VP of Innovation and Technology Deployment, Janssen Supply Chain
VP, Disease Area Stronghold Lead, Neurodegeneration
Venture Partner
Director IT
Vice President Clinical Development, Solid Tumor Franchise
CIO & VP of Business Technology
Executive Sales Representative
Managing Director - the Netherlands
Vice President, Communications, The Americas
Vice President- Global Neuroscience, Infectious Disease, Vaccines and GPH Regulatory Head